EQS-News: Instinct Bio Technical Company Holdings Inc.: Instinct Bio Returns to Profit and Grows Revenue Nearly 10% in Yen Terms in First Half of Fiscal 2026
Instinct Bio Technical Company Holdings Inc. (Nasdaq: BIOT) reported a 4.7% revenue increase to USD 1.14 million in 1H FY2026, with a 9.8% rise in yen terms. The company returned to profit, posting USD 90,251 in profit after tax, compared to a loss in the prior year. Gross margin decreased to 72.6% from 79.7%, while administrative expenses fell 30.1%. The company's largest customer's share of revenue dropped to 34.8% from 51.7%.
How this was made
The 30-second read
Why it matters
The earnings release provides the first quantitative insight into the company's post‑listing performance, setting a baseline for future guidance.
Market read
The release is a primary earnings disclosure for a newly listed micro‑cap, offering limited but actionable insight for niche investors.
What to watch
The upcoming overseas initiatives slated for 2027 could unlock future revenue streams not reflected in current numbers.
Background
Instinct Bio recently completed its Nasdaq listing in July 2026 and is now providing its first interim financial disclosure.
Ticker impact
Instinct Bio Technical Company Holdings Inc. (Nasdaq: BIOT) released its unaudited 1H FY2026 results, showing a return to profit and ~10% revenue growth in yen terms.
potential modest upside as the market prices in the profit return, tempered by cash constraints and margin pressure
First‑time earnings disclosure for a micro‑cap; profit surprise may attract short‑term buying, but limited scale and cash position limit upside.
Market effects
Highlights growth potential in Japan's regenerative‑medicine cosmetics niche, but limited impact on broader biotech sector.
May draw modest interest from Japan‑focused investors; unlikely to affect wider Asian markets.
Low global relevance due to small market cap and limited liquidity.
Counterpoint
Despite profit, the declining gross margin and minimal cash suggest the stock could face pressure if operating cash burn resumes.
Key entities
- companyInstinct Bio Technical Company Holdings Inc.
Japan‑based developer of stem‑cell‑based cosmetics, listed on Nasdaq under BIOT.
- executiveTomoki Nagano
Chairman and CEO of Instinct Bio, provided commentary on results.